BIO-TECHNE Corp — Director's Dealing 2015

Aug 20, 2015

SEC Form 4/A — Form 4/A

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-08-07

Reporting Person: Eansor Norman David (SVP - Novus Biologicals)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-07	Stock Option (Right to Buy)	$108.49	A	9375	Acquired	2022-08-07	Common Stock (9375)	Direct
2015-08-07	Restricted Stock Units	$	A	1500	Acquired		Common Stock (1500)	Direct

Footnotes

F1: Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.